Australia stock market today: ASX 200 ends higher as miners, banks climb; Endeavour and GQG slide
13 January 2026
2 mins read

Australia stock market today: ASX 200 ends higher as miners, banks climb; Endeavour and GQG slide

Sydney, January 13, 2026, 21:57 AEDT — Market closed

  • Australian shares closed up, driven by gains in miners and major banks, as energy stocks underperformed.
  • Endeavour dropped, citing margin pressure, while GQG declined following reports of net outflows.
  • Investors are shifting focus to Wednesday’s U.S. inflation figures and the RBA meeting slated for early February.

Australian shares ended Tuesday on a positive note, as the S&P/ASX 200 index climbed 0.56% to 8,808.50 points.

The gain came after a bounce back in commodity-driven risk appetite, as investors prepared for new waves of macro news amid intensified scrutiny of U.S. Federal Reserve chair Jerome Powell and escalating geopolitical tensions. “Trump is pulling at the loose threads of central bank independence,” noted Andrew Lilley, chief rates strategist at Sydney’s Barrenjoey.

Closer to home, the debate on local rates remains unsettled. Westpac’s consumer sentiment index dropped 1.7% in January. Matthew Hassan, head of Australian macro-forecasting at Westpac, warned that rising mortgage rates might “compound household caution,” intensifying the spending headwinds. (Reuters)

Miners and banks bore the brunt of the gains. Materials surged 2.0%, financials edged up 0.7%, and energy dropped 1.2%. BHP rose 2.3%, Rio Tinto added 2.2%, and gold producer Northern Star climbed 3.6%. On the downside, Ampol slipped 4.8%, while liquor retailer Endeavour Group fell 2.9%.

Endeavour reported a 1% rise in first-half group sales, reaching A$6.68 billion. However, profit before tax (pre significant items) is projected between A$400 million and A$411 million, weighed down by heavier promotions that cut retail gross margin. The company expects retail gross profit margin to fall about 85 basis points — or 0.85 percentage points — from the previous year. CEO Jayne Hrdlicka noted the group’s pricing strategy has “generated positive sales results” amid tough competition. (ASX Announcements)

GQG Partners dropped 8.6% to A$1.64 after reporting December net outflows of US$2.1 billion, pushing full-year net outflows to US$3.9 billion. The fund manager’s assets under management closed 2025 at US$163.9 billion. The firm said it maintained a “defensive positioning” through year-end and noted some relative underperformance against benchmarks. Its next funds update is scheduled for Feb. 11. (MarketScreener)

The Australian dollar held steady around $0.6707, with iron ore ticking up 0.5% to roughly $109.05 a tonne, providing some support to bulk miners as the session wound down. Attention now shifts to U.S. December consumer inflation figures, set for release early Wednesday AEDT, which could steer the next move in global interest rate expectations. (ABC)

Lithium remained in the spotlight. Prices in China jumped 9% Monday following Beijing’s announcement that it will begin phasing out value-added tax export rebates on battery products. This move drove the most-active lithium carbonate futures contract up to 156,060 yuan a tonne, Reuters reported.

A hotter-than-expected U.S. CPI reading could swiftly undercut demand for rate-sensitive sectors like tech and property, while a stronger dollar might weigh on commodity-linked stocks. Australian shares risk a setback too if local data reignites speculation about another Reserve Bank of Australia rate hike.

The next hurdle arrives swiftly: U.S. CPI data drops Wednesday, followed by the RBA board meeting on Feb. 2-3. Markets will also focus on the updated forecasts in the Statement on Monetary Policy released Feb. 3. (Reserve Bank of Australia)

Stock Market Today

  • Tempus expands oncology collaborations with NYU Langone and Northwestern Medicine; stock up 114%
    January 13, 2026, 9:11 AM EST. Tempus AI TEM expanded collaborations with leading centers to broaden access to genomic testing and data-driven cancer care. A multi-year deal with NYU Langone Health will advance genetic testing and data analysis to improve diagnostics, guide treatment and speed new test development. TEM will also support test validation, biomarker discovery, disease modeling, real-world data analysis and AI-driven prediction tools at the Perlmutter Cancer Center. In a separate pact, Northwestern Medicine will broaden genomic testing for more cancer patients, including early-stage cases, covering tissue testing, DNA and RNA profiling, liquid biopsy and MRD testing. The market note cites Illumina's TSO 500 v2 with HRD detection and CDx; and Myriad's Precise Liquid and Precise MRD. TEM shares up 114.3% year over year; the S&P 500 up about 22% in the period.
India stock market today: Sensex, Nifty end lower as tariff jitters return; Reliance drags
Previous Story

India stock market today: Sensex, Nifty end lower as tariff jitters return; Reliance drags

UK stock market today: FTSE 100 holds near a record as oil stocks rise before US inflation data
Next Story

UK stock market today: FTSE 100 holds near a record as oil stocks rise before US inflation data

Go toTop